ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
9.77
+0.07 (0.72%)
Jun 9, 2026, 4:00 PM EDT - Market closed

ImmuCell Revenue

ImmuCell had revenue of $10.36M in the quarter ending March 31, 2026, with 28.39% growth. This brings the company's revenue in the last twelve months to $29.93M, up 9.64% year-over-year. In the year 2025, ImmuCell had annual revenue of $27.64M with 4.34% growth.

Revenue (ttm)
$29.93M
Revenue Growth
+9.64%
P/S Ratio
2.95
Revenue / Employee
$410,059
Employees
73
Market Cap
88.39M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202527.64M1.15M4.34%
Dec 31, 202426.49M9.02M51.63%
Dec 31, 202317.47M-1.10M-5.90%
Dec 31, 202218.57M-675.00K-3.51%
Dec 31, 202119.24M3.90M25.43%
Dec 31, 202015.34M1.62M11.80%
Dec 31, 201913.72M2.74M24.91%
Dec 31, 201810.99M555.20K5.32%
Dec 31, 201710.43M887.14K9.30%
Dec 31, 20169.54M-684.74K-6.69%
Dec 31, 201510.23M2.63M34.64%
Dec 31, 20147.60M1.59M26.46%
Dec 31, 20136.01M617.24K11.45%
Dec 31, 20125.39M278.80K5.45%
Dec 31, 20115.11M724.94K16.53%
Dec 31, 20104.39M-119.56K-2.65%
Dec 31, 20094.51M-122.55K-2.65%
Dec 31, 20084.63M-6.21M-57.31%
Dec 31, 200710.84M1.73M19.04%
Dec 31, 20069.11M-109.26K-1.19%
Dec 31, 20059.22M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition